Refine my results

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)

Spieth, K. ; Kaufmann, R. ; Dummer, R. ; Garbe, C. ; Becker, J. C. ; Hauschild, A. ; Tilgen, W. ; Ugurel, S. ; Beyeler, M. ; Bröcker, E. B. ; Kaehler, K. C. ; Pföhler, C. ; Gille, J. ; Leiter, U. ; Schadendorf, D.

In: Annals of Oncology, 2008, vol. 19, no. 4, p. 801-806